Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
TipRanks (Mon, 10-Mar 8:00 AM ET)
Catalyst Watch: Oracle earnings, crypto swings, CPI print, and more tariff salvos
Seeking Alpha News (Fri, 7-Mar 3:00 PM ET)
Dividend ‘hopefuls’ – stocks have the ability to pay dividends but don't
Seeking Alpha News (Fri, 7-Mar 2:10 PM ET)
TipRanks (Thu, 6-Mar 7:40 AM ET)
Business Wire (Mon, 3-Mar 8:00 AM ET)
UiPath Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call
Business Wire (Wed, 12-Feb 4:10 PM ET)
Business Wire (Wed, 12-Feb 9:00 AM ET)
UiPath Report Reveals Agentic AI is Driving Investment to Tackle More Complex Business Workflows
Business Wire (Mon, 27-Jan 8:00 AM ET)
UiPath to Participate in the 27th Annual Needham Growth Conference
Business Wire (Tue, 7-Jan 4:10 PM ET)
Business Wire (Mon, 16-Dec 1:25 PM ET)
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Uipath Class A trades on the NYSE stock market under the symbol PATH.
As of March 11, 2025, PATH stock price declined to $11.89 with 8,715,081 million shares trading.
PATH has a beta of 1.85, meaning it tends to be more sensitive to market movements. PATH has a correlation of 0.19 to the broad based SPY ETF.
PATH has a market cap of $6.54 billion. This is considered a Mid Cap stock.
Last quarter Uipath Class A reported $355 million in Revenue and $.11 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.04.
In the last 3 years, PATH traded as high as $31.88 and as low as $10.37.
The top ETF exchange traded funds that PATH belongs to (by Net Assets): VTI, VB, ARKK, VGT, VXF.
PATH has underperformed the market in the last year with a price return of -49.7% while the SPY ETF gained +11.2%. PATH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.2% and -10.2%, respectively, while the SPY returned -6.5% and -5.9%, respectively.
PATH support price is $11.66 and resistance is $12.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PATH shares will trade within this expected range on the day.